Section: Pet Parasites

Tick-Borne Diseases in Dogs: Clinical Syndromes and Diagnostic Approaches

Introduction

Tick-borne diseases represent a significant and growing category of infectious diseases in canine medicine. The geographic expansion of tick vectors, driven by climatic shifts and habitat changes, has increased the exposure of domestic dogs to a complex array of bacterial, protozoal, and rickettsial pathogens. These pathogens are transmitted during the blood meal of an infected ixodid tick and can induce a spectrum of clinical syndromes ranging from subclinical infection to acute, life-threatening illness. Accurate diagnosis requires a systematic integration of signalment, history, physical examination findings, and laboratory data. This article provides a detailed review of the major tick-borne pathogens affecting dogs, their clinical presentations, and the diagnostic approaches used to confirm infection.

Major Pathogens and Their Biology

The primary tick-borne pathogens of dogs can be categorized into three groups: Gram-negative intracellular bacteria (Anaplasma, Ehrlichia, and Borrelia), protozoal hemoparasites (Babesia), and rickettsial organisms (Rickettsia rickettsii). Each pathogen has a distinct cellular tropism and mechanism of immune evasion, which dictates the clinical syndrome and the optimal diagnostic strategy.

Borrelia burgdorferi (Lyme Disease)

Borrelia burgdorferi is a spirochete bacterium transmitted primarily by Ixodes scapularis and Ixodes pacificus ticks. The organism is introduced into the dermis during tick feeding and disseminates hematogenously. Its primary target tissues include the joints, kidneys, and nervous system. The spirochete's ability to alter surface proteins (antigenic variation) allows it to evade the host immune response, leading to persistent infection.

Ehrlichia canis (Canine Monocytic Ehrlichiosis)

Ehrlichia canis is a Gram-negative, obligate intracellular bacterium that infects monocytes and macrophages. It is transmitted by Rhipicephalus sanguineus, the brown dog tick. The organism replicates within membrane-bound vacuoles (morulae) in the cytoplasm of host cells. The disease progresses through three phases: acute, subclinical, and chronic. The chronic phase is characterized by bone marrow suppression and pancytopenia.

Anaplasma phagocytophilum (Canine Granulocytic Anaplasmosis)

Anaplasma phagocytophilum infects neutrophils and is transmitted by Ixodes species ticks. The bacterium survives within neutrophil phagosomes by inhibiting phagolysosomal fusion. Infection leads to a febrile illness with thrombocytopenia and polyarthropathy.

Babesia canis and Babesia gibsoni (Canine Babesiosis)

Babesia species are protozoal hemoparasites that infect erythrocytes. Babesia canis (large form) is transmitted by Dermacentor and Rhipicephalus ticks, while Babesia gibsoni (small form) is often associated with transmission via Rhipicephalus sanguineus and also through direct blood transfer (e.g., dog fights). The parasite undergoes asexual reproduction within red blood cells, leading to hemolytic anemia.

Clinical Syndromes

The clinical presentation of tick-borne diseases in dogs is variable and often non-specific. A summary of key clinical features is provided in Table 1.

Table 1. Clinical Syndromes Associated with Major Canine Tick-Borne Pathogens

| Pathogen | Primary Target | Acute Phase Signs | Chronic/Late Signs | Key Laboratory Findings | | :-, | :-, | :-, | :-, | :-, | | Borrelia burgdorferi | Joints, Kidneys | Fever, lameness, lymphadenomegaly | Lyme nephritis (proteinuria, renal failure) | Thrombocytopenia, proteinuria | | Ehrlichia canis | Monocytes, Bone Marrow | Fever, lethargy, lymphadenopathy, bleeding tendencies | Pancytopenia, epistaxis, secondary infections | Thrombocytopenia, hyperglobulinemia | | Anaplasma phagocytophilum | Neutrophils | Fever, lethargy, polyarthropathy, vomiting | Rarely chronic; neurologic signs possible | Thrombocytopenia, mild anemia | | Babesia canis/gibsoni | Erythrocytes | Lethargy, pale mucous membranes, hemoglobinuria | Severe hemolytic anemia, splenomegaly | Regenerative anemia, thrombocytopenia, hyperbilirubinemia |

Lyme Disease (Borreliosis)

The classic clinical sign of Lyme disease in dogs is an acute, shifting leg lameness due to polyarthritis. Affected dogs may present with fever, lethargy, and regional lymphadenopathy. A hallmark of the disease is the development of Lyme nephritis, an immune-mediated glomerulonephritis that can progress to renal failure. This complication carries a poor prognosis. Neurologic signs, such as facial nerve paralysis or seizures, are reported but less common.

Canine Monocytic Ehrlichiosis (CME)

Acute CME presents with non-specific signs including fever, depression, anorexia, and petechiation due to thrombocytopenia. In the subclinical phase, dogs may appear healthy but harbor the organism for months to years. The chronic phase is the most severe, characterized by bone marrow hypoplasia leading to pancytopenia. Dogs in this phase present with epistaxis, pallor, and a high risk of secondary bacterial infections.

Canine Granulocytic Anaplasmosis

Acute anaplasmosis typically presents with a high fever, lethargy, and joint pain. Vomiting and diarrhea are occasionally reported. Thrombocytopenia is a consistent finding. Unlike ehrlichiosis, chronic disease is uncommon, and most dogs recover fully with appropriate therapy.

Canine Babesiosis

Babesiosis is primarily a hemolytic disease. Clinical signs range from mild lethargy to acute collapse with hemoglobinuria and icterus. The severity depends on the Babesia species and the host's immune status. Babesia canis often causes more severe disease than B. gibsoni. Splenomegaly is a common finding on physical examination.

Diagnostic Approaches

A definitive diagnosis of tick-borne disease requires laboratory confirmation. The choice of diagnostic test depends on the clinical presentation, the suspected pathogen, and the stage of infection. A diagnostic workflow is presented in Figure 1.

flowchart TD
    A[Clinical Suspicion: Fever, Lameness, Thrombocytopenia], > B{Point-of-Care SNAP Test}
    B, >|Positive for B. burgdorferi, E. canis, A. phagocytophilum| C[Confirmatory Testing]
    B, >|Negative| D[Consider Babesia or other pathogens]
    C, > E[Quantitative Serology & PCR]
    D, > F[Blood Smear & Babesia PCR]
    E, > G[Interpretation: Serology indicates exposure; PCR indicates active infection]
    F, > H[Blood Smear: Visualize merozoites; PCR: Species identification]
    G, > I[Initiate Targeted Therapy]
    H, > I
    I, > J[Monitor Clinical Response & Repeat CBC]

Serological Testing

Serology detects antibodies produced by the host in response to infection. It is a cornerstone of diagnosis for chronic infections where organism numbers are low.

Enzyme-Linked Immunosorbent Assay (ELISA): Commercial ELISA kits are widely used for the detection of antibodies against B. burgdorferi, E. canis, and A. phagocytophilum. These assays are often combined into a single point-of-care test. The principle involves capturing specific antibodies from the patient's serum using immobilized antigens. A positive result indicates exposure but does not differentiate between active and past infection. For B. burgdorferi, the detection of antibodies against the C6 peptide is highly specific and correlates with active infection.

Immunofluorescence Assay (IFA): IFA is a quantitative serological method used to measure antibody titers. A four-fold rise in titer between acute and convalescent samples is considered diagnostic for active infection. IFA is more labor-intensive than ELISA but provides a titer value that can be used to monitor treatment response.

Molecular Diagnostics (PCR)

Polymerase chain reaction (PCR) detects the nucleic acid of the pathogen directly. This method is highly sensitive and specific for active infection.

Conventional PCR and Real-Time PCR: Real-time PCR (qPCR) is the preferred method for most tick-borne pathogens. It allows for quantification of the pathogen load and is less prone to contamination than conventional PCR. For E. canis and A. phagocytophilum, whole blood is the preferred sample. For Babesia species, EDTA-anticoagulated blood is used. PCR is particularly useful in the acute phase of disease when antibody levels may be undetectable.

PCR Panels: Multiplex PCR assays can simultaneously detect multiple tick-borne pathogens in a single reaction. This approach is cost-effective and provides a comprehensive diagnostic profile for dogs with suspected tick-borne disease.

Hematology and Blood Smear Examination

Complete blood count (CBC) is essential for identifying hematologic abnormalities such as thrombocytopenia, anemia, and leukopenia. Examination of a thin blood smear stained with Wright-Giemsa can provide a rapid, presumptive diagnosis.

Morulae Detection: The presence of morulae (intracytoplasmic inclusions) in monocytes is diagnostic for E. canis infection. Morulae in neutrophils are diagnostic for A. phagocytophilum. This method has low sensitivity, particularly in chronic infections.

Babesia Detection: Merozoites and ring forms of Babesia can be visualized within erythrocytes on a blood smear. The sensitivity of smear examination is variable and depends on the level of parasitemia.

Urinalysis

Urinalysis is critical for the evaluation of Lyme nephritis. The detection of proteinuria via urine protein-to-creatinine ratio (UPC) is a key diagnostic finding. A UPC greater than 2.0 in a dog with positive B. burgdorferi serology is highly suggestive of Lyme nephritis.

Treatment Protocols

Treatment is directed at eliminating the pathogen and managing clinical signs. A summary of therapeutic approaches is provided in Table 2.

Table 2. Antimicrobial Therapy for Canine Tick-Borne Diseases

| Pathogen | First-Line Drug | Dose and Duration | Alternative Therapy | | :-, | :-, | :-, | :-, | | Borrelia burgdorferi | Doxycycline | 10 mg/kg PO q24h for 30 days | Amoxicillin (20 mg/kg PO q8h for 30 days) | | Ehrlichia canis | Doxycycline | 10 mg/kg PO q24h for 28 days | Imidocarb dipropionate (6.6 mg/kg IM once, repeat in 14 days) | | Anaplasma phagocytophilum | Doxycycline | 10 mg/kg PO q24h for 14-21 days | Rifampin (5-10 mg/kg PO q24h for 14 days) | | Babesia canis/gibsoni | Imidocarb dipropionate | 6.6 mg/kg IM once, repeat in 14 days | Atovaquone (13.3 mg/kg PO q8h) + Azithromycin (10 mg/kg PO q24h) for 10 days |

Supportive Care

Supportive care is critical for severe cases. Dogs with hemolytic anemia from babesiosis may require blood transfusions. Fluid therapy is indicated for dehydrated or azotemic patients. Immunosuppressive doses of corticosteroids (e.g., prednisone) may be necessary to manage immune-mediated complications such as polyarthritis or glomerulonephritis, but their use should be carefully weighed against the risk of exacerbating the infection.

Prevention Strategies

Prevention of tick-borne diseases relies on vector control and, where available, vaccination.

Tick Control

Effective tick control is the cornerstone of prevention. This involves the use of acaricidal products such as isoxazoline compounds (e.g., fluralaner, afoxolaner, sarolaner) administered orally or topically. These drugs provide rapid killing of ticks and can reduce the risk of pathogen transmission. Environmental management, including yard maintenance and avoidance of tick-infested areas, is also important.

Vaccination

A vaccine for Lyme disease is available for dogs. It targets outer surface proteins (OspA and OspC) of B. burgdorferi. Vaccination does not prevent infection but reduces the severity of clinical disease and may decrease the risk of Lyme nephritis. No vaccines are currently available for ehrlichiosis, anaplasmosis, or babesiosis.

Routine Screening

Annual screening of dogs in endemic areas using point-of-care ELISA tests is recommended. Early detection of subclinical infection allows for prompt treatment and reduces the risk of chronic disease.

Conclusion

Tick-borne diseases in dogs represent a complex diagnostic challenge due to overlapping clinical signs and the potential for co-infections. A systematic approach combining serology, molecular diagnostics, and hematology is essential for accurate diagnosis. Doxycycline remains the cornerstone of therapy for most bacterial tick-borne infections, while babesiosis requires specific antiprotozoal agents. Prevention through rigorous tick control and vaccination for Lyme disease is the most effective strategy for reducing disease burden. Continued surveillance and research into emerging tick-borne pathogens are necessary to adapt diagnostic and therapeutic protocols.

References

  1. Littman MP, Gerber B, Goldstein RE, et al. ACVIM consensus update on Lyme borreliosis in dogs and cats. Journal of Veterinary Internal Medicine. 2018;32(3):887-903.
  2. Neer TM, Breitschwerdt EB, Greene RT, et al. Consensus statement on ehrlichial disease of small animals from the infectious disease study group of the ACVIM. Journal of Veterinary Internal Medicine. 2002;16(3):309-315.
  3. Kidd L, Breitschwerdt EB. Transmission times and prevention of tick-borne diseases in dogs. Compendium on Continuing Education for the Practicing Veterinarian. 2003;25(10):742-751.
  4. Birkenheuer AJ, Levy MG, Breitschwerdt EB. Development and evaluation of a seminested PCR for detection and differentiation of Babesia gibsoni (Asian genotype) and B. canis DNA in canine blood samples. Journal of Clinical Microbiology. 2003;41(9):4172-4177.
  5. Carrade DD, Foley JE, Borjesson DL, et al. Canine granulocytic anaplasmosis: a review. Journal of Veterinary Internal Medicine. 2009;23(6):1129-1141.